Here’s what you need to know.
1. The trial’s first half focused on whether the merger would hinder competition in national markets.
2. WBAA spoke to Saint Louis University antitrust specialist Tim Greaney. Mr. Greaney said the Department of Justice has submitted ample evidence to prove the two companies are competing for national insurance contracts.
Mr. Greaney sees Cigna as a smaller force, undercutting Anthem and keeping the larger company “on its toes.”
3. If the federal judge finds the arguments from the DOJ convincing enough, she could indefinitely postpone the second half of the trial, which would examine the merger’s effect on small markets.
More articles on coding, billing and collections:
Best practices for coding & billing 4 common GYN procedures
Columnist: Health industry lobbies to keep ACA customers — 4 takeaways
Pelosi: Democrats don’t support Medicare, VA privatization
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
